Status:
COMPLETED
Effects of Pioglitazone in Hypertensive Patients
Lead Sponsor:
Tottori University Hospital
Conditions:
Hypertension
Insulin Resistance
Eligibility:
All Genders
20+ years
Phase:
PHASE4
Brief Summary
Insulin resistance is often complicated with hypertension. AGE and inflammation play important roles in insulin resistance. Some studies reported that pioglitazone, insulin sensitizer, is effective fo...
Eligibility Criteria
Inclusion
- Hypertension with insulin resistance
Exclusion
- Chronic systolic heart failure, ACS
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01472497
Start Date
April 1 2007
End Date
March 1 2012
Last Update
June 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tottori University Hospital
Yonago, Japan, 683-8504